Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
The company has been awarded a contract for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan
Subscribe To Our Newsletter & Stay Updated
